Industry Roundup: UK, US Claim Enforcement, Green Blender Expanding
This article was originally published in The Tan Sheet
Executive Summary
UK Hylo-Tear claim fails; Golden Caviar warned on anti-inflammatory claims, $1M for Green Blender expansion; Lycored updates logo, slogan; and more news in brief.
You may also be interested in...
Petition Challenges California Prop 65 Safe Harbor For Lead
In parallel with a lawsuit brought by the Mateel Environmental Justice Foundation, which seeks to eliminate the safe-harbor level for lead under Proposition 65, the Center for Environmental Health has filed a petition with California OEHHA asking for repeal or amendment of lead's maximum allowable dose level.
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.
China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’
China’s public payer perceives innovative drugs in a different way from that of the country’s top drug regulator, a former senior healthcare security official with knowledge of the matter reveals. The posture has unnerved pharma companies, which have been hit by sharp price discounts.